These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7197592)

  • 1. Treatment of an Nb-Pr-A.I.-3 (autonomous) tumor with combination chemotherapy.
    Drago JR; Worgul T
    Cancer Chemother Pharmacol; 1981; 5(3):163-6. PubMed ID: 7197592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapeutic treatment of the Nb rat adenocarcinoma androgen-insensitive tumor III.
    Drago JR
    J Surg Oncol; 1982 Dec; 21(4):264-6. PubMed ID: 7144207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple drug chemotherapy in treatment of prostate adenocarcinoma Nb Pr A.I.-III.
    Drago JR; Worgul TJ
    Invest Urol; 1981 Nov; 19(3):191-3. PubMed ID: 7298290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy in a prostate tumor model: Nb rat prostatic adenocarcinoma model.
    Drago JR; Worgul T; Gershwin ME
    J Surg Oncol; 1981; 16(4):353-63. PubMed ID: 7195962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy of the transplantable adenocarcinoma (R-3327) of the Copenhagen rat.
    Block NL; Camuzzi F; Denefrio J; Troner M; Claflin A; Stover B; Politano VA
    Oncology; 1977; 34(3):110-3. PubMed ID: 917440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further experience with chemotherapy in the Dunning prostatic adenocarcinoma.
    Block NL; Camuzzi F; Stover B; Claflin A; Troner M; Politano VA
    Trans Am Assoc Genitourin Surg; 1978; 70():57-9. PubMed ID: 753023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat (Pr-90) prostatic carcinoma.
    Drago JR; Goldman LB
    Cancer; 1980 Feb; 45(4):757-63. PubMed ID: 7357493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic manipulation of Nb rat prostatic adenocarcinomas: chemotherapeutic evaluation of autonomous tumors.
    Drago JR; Goldman LB; Maurer RE; Gershwin ME; Eckels DD
    Invest Urol; 1979 Nov; 17(3):203-6. PubMed ID: 500317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat prostate adenocarcinoma: autonomous tumor (18-Pr and 13-Pr).
    Drago JR; Goldman LB; Gershwin ME
    Cancer; 1980 Jul; 46(2):273-8. PubMed ID: 7388771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin.
    Drago JR; Goldman L; Gershwin ME
    Invest Urol; 1980 Jul; 18(1):80-1. PubMed ID: 7410017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterotransplantation of Nb rat prostatic adenocarcinomas into congenitally athymic nude mice.
    Drago JR; Gershwin ME
    Cancer; 1981 Jan; 47(1):55-9. PubMed ID: 7193077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nb rat prostate adenocarcinoma model: evaluation of the subrenal capsular assay system.
    Drago JR; Lombard J
    J Surg Oncol; 1985 Apr; 28(4):270-2. PubMed ID: 3884903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis in the androgen-insensitive Nb rat prostatic carcinoma system.
    Drago JR; Lombard JS
    J Surg Oncol; 1985 Apr; 28(4):252-6. PubMed ID: 4039015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined cyclophosphamide chemotherapy and maltose tetrapalmitate immunotherapy in the treatment of transplanted bladder and prostate carcinoma of the rat.
    Ibrahiem EH; Nigam VN; Brailovsky CA; Backman BD; Elhilali MM
    Cancer Res; 1984 Feb; 44(2):536-42. PubMed ID: 6537897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer.
    Higby DJ; Wilbur D; Wallace HJ; Henderson ES; Weiss R
    Cancer Treat Rep; 1977 Aug; 61(5):869-73. PubMed ID: 329980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Nb rat prostatic adenocarcinoma's dose response to methotrexate and adriamycin.
    Drago JR; Palmer J
    J Surg Oncol; 1983 Nov; 24(3):215-7. PubMed ID: 6632910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy and concomitant chemoradiotherapy in the NB rat prostate adenocarcinoma model.
    Klump R; Pieters RS; Smith JJ; Badalament RA; Drago JR
    In Vivo; 1989; 3(2):109-11. PubMed ID: 2519835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of the Nb rat in combination chemotherapeutic experiments for prostate cancer.
    Drago JR; Smith J
    In Vivo; 1991; 5(1):41-2. PubMed ID: 1932624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adriamycin-vitamin E combination therapy for treatment of prostate adenocarcinoma in the Nb rat model.
    Nesbitt JA; Smith J; McDowell G; Drago JR
    J Surg Oncol; 1988 Aug; 38(4):283-4. PubMed ID: 3411971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synergistic effect of hyperthermia and chemotherapy on murine transitional cell carcinoma.
    Haas GP; Klugo RC; Hetzel FW; Barton EE; Cerny JC
    J Urol; 1984 Oct; 132(4):828-33. PubMed ID: 6540817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.